| Basics |
VanEck Vectors Biotech ETF
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index.
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
|
| IPO Date: |
December 1, 1999 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.22 | 0.91%
|
| Avg Daily Range (30 D): |
$2.69 | 1.86%
|
| Avg Daily Range (90 D): |
$1.80 | 1.18%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.16M |
| Avg Daily Volume (30 D): |
.02M |
| Avg Daily Volume (90 D): |
.01M |
| Trade Size |
| Avg Trade Size (Sh.): |
294 |
| Avg Trade Size (Sh.) (30 D): |
133 |
| Avg Trade Size (Sh.) (90 D): |
131 |
| Institutional Trades |
| Total Inst.Trades: |
8,106 |
| Avg Inst. Trade: |
$3.71M |
| Avg Inst. Trade (30 D): |
$5.61M |
| Avg Inst. Trade (90 D): |
$3.31M |
| Avg Inst. Trade Volume: |
.07M |
| Avg Inst. Trades (Per Day): |
5 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.59M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
42.75K |
|
|
|
|
|
